Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

Components in Plasma-Derived Factor VIII, But Not in Recombinant Factor VIII Downregulate Anti-Inflammatory Surface Marker CD163 in Human Macrophages through Release of CXCL4 (Platelet Factor 4).

Bertling A, Brodde MF, Visser M, Treffon J, Fennen M, Fender AC, Kelsch R, Kehrel BE.

Transfus Med Hemother. 2017 Sep;44(5):351-357. doi: 10.1159/000472157. Epub 2017 Aug 11.

2.

Smad-dependent mechanisms of inflammatory bone destruction.

Fennen M, Pap T, Dankbar B.

Arthritis Res Ther. 2016 Dec 1;18(1):279. Review.

3.

Sclerostin inhibition promotes TNF-dependent inflammatory joint destruction.

Wehmeyer C, Frank S, Beckmann D, Böttcher M, Cromme C, König U, Fennen M, Held A, Paruzel P, Hartmann C, Stratis A, Korb-Pap A, Kamradt T, Kramer I, van den Berg W, Kneissel M, Pap T, Dankbar B.

Sci Transl Med. 2016 Mar 16;8(330):330ra35. doi: 10.1126/scitranslmed.aac4351. Epub 2016 Mar 16.

PMID:
27089204
4.

Myostatin is a direct regulator of osteoclast differentiation and its inhibition reduces inflammatory joint destruction in mice.

Dankbar B, Fennen M, Brunert D, Hayer S, Frank S, Wehmeyer C, Beckmann D, Paruzel P, Bertrand J, Redlich K, Koers-Wunrau C, Stratis A, Korb-Pap A, Pap T.

Nat Med. 2015 Sep;21(9):1085-90. doi: 10.1038/nm.3917. Epub 2015 Aug 3.

PMID:
26236992

Supplemental Content

Loading ...
Support Center